卓越新能(688196) - 2023 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2023 was ¥708,758,172.15, a decrease of 48.04% compared to the same period last year[5] - The net profit attributable to shareholders was ¥1,344,712.98, down 99.19% year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥7,306,890.96, a decline of 95.20% compared to the previous year[5] - Basic earnings per share were ¥0.01, a drop of 99.27% from the same period last year[6] - Total operating revenue for the first three quarters of 2023 was CNY 2,537,971,941.42, a decrease of 30% compared to CNY 3,625,037,817.75 in the same period of 2022[19] - Net profit for the first three quarters of 2023 was CNY 153,050,414.48, a decline of 64.4% compared to CNY 430,179,729.89 in the same period of 2022[20] - Earnings per share for the third quarter of 2023 was CNY 1.28, down from CNY 3.58 in the same quarter of the previous year[20] - The company reported a total of CNY 148,948,575.64 in other income for the first three quarters of 2023, down from CNY 232,815,448.93 in the previous year[20] Cash Flow and Liquidity - The cash flow from operating activities showed a net decrease of 78.60%, totaling ¥115,205,933.67[6] - Cash inflow from operating activities for the first three quarters of 2023 was approximately ¥2.89 billion, a decrease of 32.2% compared to ¥4.27 billion in the same period of 2022[23] - Net cash flow from operating activities for the first three quarters of 2023 was ¥115.21 million, down 78.6% from ¥538.30 million in the first three quarters of 2022[23] - Total cash inflow from investment activities for the first three quarters of 2023 was ¥466.10 million, a significant decline of 85.0% compared to ¥3.10 billion in the same period of 2022[24] - Net cash flow from investment activities for the first three quarters of 2023 was -¥473.80 million, worsening from -¥212.30 million in the first three quarters of 2022[24] - Cash inflow from financing activities in the first three quarters of 2023 was ¥270.00 million, compared to ¥54.22 million in the same period of 2022, indicating a substantial increase[24] - Net cash flow from financing activities for the first three quarters of 2023 was ¥4.68 million, recovering from a negative cash flow of -¥94.40 million in the first three quarters of 2022[24] - The cash and cash equivalents at the end of Q3 2023 stood at ¥327.78 million, down from ¥578.49 million at the end of Q3 2022[24] - The company experienced a negative impact of ¥40.89 million from exchange rate fluctuations on cash and cash equivalents in Q3 2023[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,164,886,070.33, an increase of 6.01% compared to the end of the previous year[6] - As of September 30, 2023, the total assets of the company reached RMB 3,164,886,070.33, an increase from RMB 2,985,496,321.24 at the end of 2022, reflecting a growth of approximately 6%[16] - The company's cash and cash equivalents decreased to RMB 327,784,203.18 from RMB 722,589,110.95, representing a decline of about 54%[16] - The accounts receivable increased significantly to RMB 243,323,150.89 from RMB 1,117,977.31, indicating a substantial rise in credit sales[16] - The company's inventory decreased to RMB 296,835,686.77 from RMB 473,492,418.58, showing a reduction of approximately 37%[17] - Non-current assets totaled RMB 1,497,282,222.26, up from RMB 1,063,690,833.00, marking an increase of around 41%[17] - The total liabilities of the company were not explicitly stated, but the accounts payable decreased to RMB 34,086,586.94 from RMB 54,747,652.80, a reduction of about 38%[17] - Total liabilities as of the end of the third quarter of 2023 amounted to CNY 414,029,971.64, compared to CNY 201,690,637.03 at the end of the previous year, indicating a significant increase[19] - Total equity attributable to shareholders was CNY 2,750,856,098.69, slightly down from CNY 2,783,805,684.21 in the previous year[19] Research and Development - Research and development expenses amounted to ¥38,907,749.01, a decrease of 26.62% year-on-year, representing 5.49% of operating revenue[6] - Research and development expenses for the first three quarters of 2023 were CNY 111,828,896.75, a decrease of 27% from CNY 154,102,483.98 in the same period of 2022[19] - The company is currently engaged in ongoing research and development for new products and technologies, although specific details were not disclosed in the report[15] Market Strategy - The company experienced a significant decline in sales volume and prices, particularly in biodiesel, impacting revenue[10] - The company is exploring market expansion opportunities, but no specific strategies or targets were mentioned in the conference call[15] - There were no significant mergers or acquisitions reported during the quarter, and the company is focusing on internal growth strategies[15] - The company plans to focus on market expansion and new product development in the upcoming quarters to enhance revenue growth[22]